Home ›
Trademark Categories ›
Pharmaceuticals ›
2007 ›
TA ›
TARLEVO
Trademark search for:
TARLEVO
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2007-09-19 — Application filed
2007-11-15 — Sn assigned for sect 66a appl from ib
2007-11-16 — Application filed
2007-12-22 — Assigned to examiner
2007-12-30 — Final disposition recorded
2007-12-31 — Office action issued
2008-01-02 — Office action issued
2008-01-02 — Office action issued
2008-01-24 — Office action issued
2008-06-30 — Paper received
2008-07-02 — Amendment from applicant entered
2008-07-02 — Assigned to lie
2008-07-02 — Correspondence received in law office
2008-07-27 — Attorney/dom.rep.revoked and/or appointed
2008-07-27 — Teas revoke/app/change addr of atty/dom rep received
2008-07-30 — Approved for pub - principal register
2008-07-31 — Law office publication review completed
2008-08-13 — Notice of publication
2008-09-02 — Published for opposition
2008-11-18 — Registered-principal register
2009-02-18 — Final disposition recorded
2009-03-10 — Final disposition recorded
2009-03-10 — Final disposition recorded
2010-01-13 — Teas change of correspondence received
2012-05-11 — Change of owner received from ib
2012-07-06 — Attorney/dom.rep.revoked and/or appointed
2012-07-06 — Teas revoke/app/change addr of atty/dom rep received
2013-04-14 — Final disposition recorded
2013-05-30 — Teas change of correspondence received
2015-06-19 — Cancelled section 71
2015-06-19 — Final status recorded
2016-02-19 — Total invalidation of reg ext protection created
2016-04-11 — Total invalidation of reg ext protection sent to ib
2016-04-11 — Invalidation processed
2017-03-31 — Total invalidation processed by the ib
Owner Information
Actelion Pharmaceuticals Ltd
UCB PHARMA S.A.
UCB PHARMA S.A.
UCB PHARMA S.A.
Correspondent
Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
